156 related articles for article (PubMed ID: 30571186)
1. Biomarker Glycoprotein Acetyls Is Associated With the Risk of a Wide Spectrum of Incident Diseases and Stratifies Mortality Risk in Angiography Patients.
Kettunen J; Ritchie SC; Anufrieva O; Lyytikäinen LP; Hernesniemi J; Karhunen PJ; Kuukasjärvi P; Laurikka J; Kähönen M; Lehtimäki T; Havulinna AS; Salomaa V; Männistö S; Ala-Korpela M; Perola M; Inouye M; Würtz P
Circ Genom Precis Med; 2018 Nov; 11(11):e002234. PubMed ID: 30571186
[TBL] [Abstract][Full Text] [Related]
2. GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function.
Gruppen EG; Riphagen IJ; Connelly MA; Otvos JD; Bakker SJ; Dullaart RP
PLoS One; 2015; 10(9):e0139057. PubMed ID: 26398105
[TBL] [Abstract][Full Text] [Related]
3. GlycA, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: PREVEND study.
Connelly MA; Gruppen EG; Wolak-Dinsmore J; Matyus SP; Riphagen IJ; Shalaurova I; Bakker SJ; Otvos JD; Dullaart RP
Clin Chim Acta; 2016 Jan; 452():10-7. PubMed ID: 26549655
[TBL] [Abstract][Full Text] [Related]
4. GlycA, a novel pro-inflammatory glycoprotein biomarker is associated with mortality: results from the PREVEND study and meta-analysis.
Gruppen EG; Kunutsor SK; Kieneker LM; van der Vegt B; Connelly MA; de Bock GH; Gansevoort RT; Bakker SJL; Dullaart RPF
J Intern Med; 2019 Nov; 286(5):596-609. PubMed ID: 31260573
[TBL] [Abstract][Full Text] [Related]
5. GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: The intermountain heart collaborative study.
Muhlestein JB; May HT; Galenko O; Knowlton KU; Otvos JD; Connelly MA; Lappe DL; Anderson JL
Am Heart J; 2018 Aug; 202():27-32. PubMed ID: 29803983
[TBL] [Abstract][Full Text] [Related]
6. Circulating N-Linked Glycoprotein Side-Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial.
Akinkuolie AO; Glynn RJ; Padmanabhan L; Ridker PM; Mora S
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27413042
[TBL] [Abstract][Full Text] [Related]
7. Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk.
Lawler PR; Akinkuolie AO; Chandler PD; Moorthy MV; Vandenburgh MJ; Schaumberg DA; Lee IM; Glynn RJ; Ridker PM; Buring JE; Mora S
Circ Res; 2016 Apr; 118(7):1106-15. PubMed ID: 26951635
[TBL] [Abstract][Full Text] [Related]
8. A novel protein glycan biomarker and future cardiovascular disease events.
Akinkuolie AO; Buring JE; Ridker PM; Mora S
J Am Heart Assoc; 2014 Sep; 3(5):e001221. PubMed ID: 25249300
[TBL] [Abstract][Full Text] [Related]
9. Association of N-Linked Glycoprotein Acetyls and Colorectal Cancer Incidence and Mortality.
Chandler PD; Akinkuolie AO; Tobias DK; Lawler PR; Li C; Moorthy MV; Wang L; Duprez DA; Jacobs DR; Glynn RJ; Otvos J; Connelly MA; Post WS; Ridker PM; Manson JE; Buring JE; Lee IM; Mora S
PLoS One; 2016; 11(11):e0165615. PubMed ID: 27902713
[TBL] [Abstract][Full Text] [Related]
10. A Novel Protein Glycan-Derived Inflammation Biomarker Independently Predicts Cardiovascular Disease and Modifies the Association of HDL Subclasses with Mortality.
McGarrah RW; Kelly JP; Craig DM; Haynes C; Jessee RC; Huffman KM; Kraus WE; Shah SH
Clin Chem; 2017 Jan; 63(1):288-296. PubMed ID: 27811210
[TBL] [Abstract][Full Text] [Related]
11. A novel protein glycan biomarker and LCAT activity in metabolic syndrome.
Gruppen EG; Connelly MA; Otvos JD; Bakker SJ; Dullaart RP
Eur J Clin Invest; 2015 Aug; 45(8):850-9. PubMed ID: 26081900
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Predictive Value of GlycA and Other Biomarkers of Inflammation for Total Death, Incident Cardiovascular Events, Noncardiovascular and Noncancer Inflammatory-Related Events, and Total Cancer Events.
Duprez DA; Otvos J; Sanchez OA; Mackey RH; Tracy R; Jacobs DR
Clin Chem; 2016 Jul; 62(7):1020-31. PubMed ID: 27173011
[TBL] [Abstract][Full Text] [Related]
13. GlycA, a novel proinflammatory glycoprotein biomarker, and high-sensitivity C-reactive protein are inversely associated with sodium intake after controlling for adiposity: the Prevention of Renal and Vascular End-Stage Disease study.
Gruppen EG; Connelly MA; Vart P; Otvos JD; Bakker SJ; Dullaart RP
Am J Clin Nutr; 2016 Aug; 104(2):415-22. PubMed ID: 27305953
[TBL] [Abstract][Full Text] [Related]
14. Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial.
Otvos JD; Guyton JR; Connelly MA; Akapame S; Bittner V; Kopecky SL; Lacy M; Marcovina SM; Muhlestein JB; Boden WE
J Clin Lipidol; 2018; 12(2):348-355.e2. PubMed ID: 29409728
[TBL] [Abstract][Full Text] [Related]
15. GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis.
Joshi AA; Lerman JB; Aberra TM; Afshar M; Teague HL; Rodante JA; Krishnamoorthy P; Ng Q; Aridi TZ; Salahuddin T; Natarajan B; Lockshin BN; Ahlman MA; Chen MY; Rader DJ; Reilly MP; Remaley AT; Bluemke DA; Playford MP; Gelfand JM; Mehta NN
Circ Res; 2016 Nov; 119(11):1242-1253. PubMed ID: 27654120
[TBL] [Abstract][Full Text] [Related]
16. GlycA: A New Biomarker for Systemic Inflammation and Cardiovascular Disease (CVD) Risk Assessment.
Ballout RA; Remaley AT
J Lab Precis Med; 2020 Apr; 5():. PubMed ID: 32363327
[TBL] [Abstract][Full Text] [Related]
17. Glycoprotein Acetyls Associate With Intraglomerular Hemodynamic Dysfunction, Albuminuria, Central Adiposity, and Insulin Resistance in Youth With Type 1 Diabetes.
McGee AC; Reinicke T; Carrasco D; Goodrich J; Pavkov ME; van Raalte DH; Birznieks C; Nelson RG; Nadeau KJ; Choi YJ; Vigers T; Pyle L; de Boer I; Bjornstad P; Tommerdahl KL
Can J Diabetes; 2024 Jun; 48(4):244-249.e1. PubMed ID: 38341135
[TBL] [Abstract][Full Text] [Related]
18. GlycA for long-term outcome in T2DM secondary prevention.
Zierfuss B; Höbaus C; Herz CT; Pesau G; Mrak D; Koppensteiner R; Schernthaner GH
Diabetes Res Clin Pract; 2021 Jan; 171():108583. PubMed ID: 33307129
[TBL] [Abstract][Full Text] [Related]
19. Glycoprotein Acetyls: A Novel Inflammatory Biomarker of Early Cardiovascular Risk in the Young.
Chiesa ST; Charakida M; Georgiopoulos G; Roberts JD; Stafford SJ; Park C; Mykkänen J; Kähönen M; Lehtimäki T; Ala-Korpela M; Raitakari O; Pietiäinen M; Pussinen P; Muthurangu V; Hughes AD; Sattar N; Timpson NJ; Deanfield JE
J Am Heart Assoc; 2022 Feb; 11(4):e024380. PubMed ID: 35156387
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the stability of glycoprotein acetyls and high sensitivity C-reactive protein as markers of chronic inflammation.
Crick DCP; Khandaker GM; Halligan SL; Burgner D; Mansell T; Fraser A
Immunology; 2024 Apr; 171(4):497-512. PubMed ID: 38148627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
